Pharmacokinetics and Clinical Use of Flumazenil (Ro 15-1788)
- 1 January 1988
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 14 (1), 1-12
- https://doi.org/10.2165/00003088-198814010-00001
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Benzodiazepine antagonist Ro 15‐1788Anaesthesia, 1986
- Fatal Familial Insomnia and Dysautonomia with Selective Degeneration of Thalamic NucleiNew England Journal of Medicine, 1986
- Ro 15‐1788 for postoperative recoveryAnaesthesia, 1986
- Pharmacodynamic Interaction Between Midazolam and a Specific Benzodiazepine Antagonist in HumansThe Journal of Clinical Pharmacology, 1985
- REVERSAL OF HEPATIC COMA BY BENZODIAZEPINE ANTAGONIST (Ro 15-1788)The Lancet, 1985
- Effects of a Benzodiazepine Antagonist on the Diazepam-Induced Electrical Brain Activity ModificationsNeuropsychobiology, 1984
- SEVERE ANXIETY INDUCED BY FG 7142, A β-CARBOLINE LIGAND FOR BENZODIAZEPINE RECEPTORSThe Lancet, 1983
- First Clinical Investigation of the Benzodiazepine Antagonist Ro 15-1788 in Comatose PatientsEuropean Neurology, 1983
- REVERSAL OF BENZODIAZEPINE-INDUCED SEDATION BY INTRAVENOUS Ro 15-1788The Lancet, 1981
- Selective antagonists of benzodiazepinesNature, 1981